Published in J Clin Invest on February 01, 1977
Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med (1979) 3.61
Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte. J Exp Med (1979) 3.19
H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest (1977) 2.71
Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides. J Exp Med (1978) 2.45
In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states. Infect Immun (1978) 2.33
Changes in membrane potential of human granulocytes antecede the metabolic responses to surface stimulation. Proc Natl Acad Sci U S A (1978) 2.33
Subcellular localization of the superoxide-forming enzyme in human neutrophils. J Clin Invest (1979) 2.33
Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol (1983) 2.32
Differences in the ingestion mechanisms of IgG and C3b particles in phagocytosis by neutrophils. Immunology (1982) 2.04
Termination of the respiratory burst in human neutrophils. J Clin Invest (1978) 1.80
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J Clin Invest (1978) 1.66
Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J Clin Invest (1983) 1.54
Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production. J Exp Med (1977) 1.36
Mannose-sensitive stimulation of human leukocyte chemiluminescence by Escherichia coli. Infect Immun (1979) 1.33
Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect Immun (1979) 1.32
NAD(P)H oxidase activity in human neutrophils stimulated by phorbol myristate acetate. J Clin Invest (1980) 1.26
Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion. Proc Natl Acad Sci U S A (1980) 1.25
Cell biology of leukocyte abnormalities--membrane and cytoskeletal function in normal and defective cells. A review. Am J Pathol (1978) 1.23
Fluoride-mediated activation of the respiratory burst in human neutrophils. A reversible process. J Clin Invest (1979) 1.23
Modes of action of aspirin-like drugs. Proc Natl Acad Sci U S A (1985) 1.18
Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. J Clin Invest (1980) 1.15
Effect of chemoattractants on chemiluminescence. Infect Immun (1978) 1.14
Inhibition of superoxide production in human polymorphonuclear leukocytes by oral treponemal factors. Infect Immun (1988) 1.13
Arrangement of the respiratory burst oxidase in the plasma membrane of the neutrophil. J Clin Invest (1981) 1.10
Role of hydrogen peroxide and peroxidase in the cytotoxicity of Trypanosoma dionisii by human granulocytes. Infect Immun (1978) 1.04
Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J Clin Invest (1981) 1.03
Effect of calcium on superoxide production by phagocytic vesicles from rabbit alveolar macrophages. J Clin Invest (1981) 1.03
Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog. Infect Immun (1982) 0.96
Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infections. Infect Immun (1980) 0.95
Evidence for the role of superoxide radicals in neutrophil-mediated cytotoxicity. Immunology (1979) 0.89
Heparin inhibits phagocytosis by polymorphonuclear leukocytes. Infect Immun (1981) 0.89
Superoxide production in pulmonary alveolar macrophages and killing of BCG by the superoxide-generating system with or without catalase. Infect Immun (1979) 0.88
Conceptual bases for prey biorecognition and feeding selectivity in the microplanktonic marine phagotroph Oxyrrhis marina. Microb Ecol (2008) 0.87
Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol (1989) 0.87
Exploiting oxidative microenvironments in the body as triggers for drug delivery systems. Antioxid Redox Signal (2014) 0.83
Dual effects of guanosine 5'-[gamma-thio]triphosphate on secretion by electroporated human neutrophils. Biochem J (1991) 0.81
Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat. J Clin Invest (1983) 0.80
Free radical generation by neutrophils: a potential mechanism of cellular injury in acute alcoholic hepatitis. Gut (1987) 0.78
Studies in normal and chronic granulomatous disease neutrophils indicate a correlation of tubulin tyrosinolation with the cellular redox state. J Clin Invest (1983) 0.78
The effect of acrylamide on human polymorphonuclear neutrophils in vitro. Br J Ind Med (1978) 0.75
Free radicals in colitis. Gut (1991) 0.75
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut (1987) 0.75
The radiosensitivity of rat thymocytes. Biochem J (1986) 0.75
Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study. J Biol Inorg Chem (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83
Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest (1973) 17.56
Lectins: cell-agglutinating and sugar-specific proteins. Science (1972) 8.46
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest (1974) 3.78
Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol (1967) 3.53
Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 3.38
Superoxide dismutases in polymorphonuclear leukocytes. J Clin Invest (1974) 3.29
Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol (1975) 3.24
Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med (1975) 3.24
Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose. J Clin Invest (1975) 3.17
Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med (1956) 3.17
Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase. J Clin Invest (1975) 3.04
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85
Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. I. Evidence for an ecto-adenosine monophosphatase, adenosine triphosphatase, and -p-nitrophenyl phosphates. J Biol Chem (1974) 2.65
Sulfanilic acid diazonium salt: a label for the outside of the human erythrocyte membrane. Biochim Biophys Acta (1969) 2.48
Concanavalin A induces microtubule assembly and specific granule discharge in human polymorphonuclear leukocytes. J Cell Biol (1976) 2.08
Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol (1974) 2.02
Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97
The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med (1974) 1.92
Reversible metabolic stimulation of polymorphonuclear leukocytes and macrophages by concanavalin A. Nat New Biol (1973) 1.73
Effect of specific antibodies on the metabolism of guinea pig polymorphonuclear leukocytes. J Reticuloendothel Soc (1971) 1.48
Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. J Immunol (1975) 1.43
The reactions of diazonium compounds with amino acids and proteins. Biochem J (1957) 1.29
Studies on mitochondrial proteins. II. Localization of components in the inner membrane: labeling with diazobenzenesulfonate, a non-penetrating probe. Biochim Biophys Acta (1974) 1.11
Polymorphonuclear leukocyte activation: effects of phospholipase C. Proc Soc Exp Biol Med (1972) 1.01
Stimulation of glucose oxidation in human polymorphonuclear leucocytes by C3-Sepharose and soluble C567. FEBS Lett (1975) 0.90
Reaction of amino acids and proteins with diazonium compounds. II. Spectra of protein derivatives. Arch Biochem Biophys (1959) 0.90
Biofilm formation as microbial development. Annu Rev Microbiol (2000) 13.33
Diffusion of autoinducer is involved in regulation of the Vibrio fischeri luminescence system. J Bacteriol (1985) 7.79
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA (1993) 4.36
The brief MAST: a shortened version of the Michigan Alcoholism Screening Test. Am J Psychiatry (1972) 4.12
Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 3.38
Evolution of sensory complexity recorded in a myxobacterial genome. Proc Natl Acad Sci U S A (2006) 3.35
Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1974) 3.24
Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. J Immunol (1973) 2.66
Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging (2004) 2.41
Potassium and amino acid transport in human leukocytes exposed to phagocytic stimuli. J Cell Biol (1974) 2.16
Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol (1974) 2.02
Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97
A new set of chemotaxis homologues is essential for Myxococcus xanthus social motility. Mol Microbiol (1998) 1.91
Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate. J Cell Biol (1975) 1.87
Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem (1979) 1.84
Implementation of program change in community agencies. Milbank Mem Fund Q (1967) 1.82
Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation. J Cell Biol (1977) 1.69
Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62
Myxococcus xanthus dif genes are required for biogenesis of cell surface fibrils essential for social gliding motility. J Bacteriol (2000) 1.61
Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med (1973) 1.61
The Myxococcus xanthus lipopolysaccharide O-antigen is required for social motility and multicellular development. Mol Microbiol (1998) 1.60
Thromboxane generation by human peripheral blood polymorphonuclear leukocytes. J Exp Med (1978) 1.57
Characteristics of black patients admitted to coronary care units in metropolitan Seattle: results from the Myocardial Infarction Triage and Intervention Registry (MITI). Am J Cardiol (1991) 1.51
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res (1988) 1.46
Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. J Biol Chem (1984) 1.44
Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. J Immunol (1975) 1.43
Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes. J Immunol (1975) 1.43
Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci (1998) 1.43
An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest (1990) 1.41
Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer (1970) 1.39
Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production. J Exp Med (1977) 1.36
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J Immunol (1985) 1.30
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28
Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis (1984) 1.28
Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol (1989) 1.27
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27
A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol (1991) 1.26
Pathways to adolescent drug use: self-derogation, peer influence, weakening of social controls, and early substance use. J Health Soc Behav (1984) 1.25
The Myxococcus xanthus rfbABC operon encodes an ATP-binding cassette transporter homolog required for O-antigen biosynthesis and multicellular development. J Bacteriol (1996) 1.22
Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest (1989) 1.22
Characterization of polymorphic forms of Fc receptor III on human neutrophils. J Clin Invest (1989) 1.21
Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450. J Clin Invest (1985) 1.15
Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. J Clin Invest (1984) 1.14
Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells. J Immunol (1986) 1.13
Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Suicidal inactivation by acetylenic fatty acids. J Biol Chem (1985) 1.12
The roles of degranulation and superoxide anion generation in neutrophil aggregation. Biochim Biophys Acta (1982) 1.11
Nonphagocytic stimulation of human polymorphonuclear leukocytes: role of the plasma membrane. Semin Hematol (1979) 1.10
Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro. Am J Pathol (1983) 1.10
Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors. Infect Immun (1985) 1.09
Neutrophil degranulation. Contemp Top Immunobiol (1984) 1.09
Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol (1984) 1.08
Effect of steroids on lysosomes. Transplant Proc (1975) 1.08
Stability of psychological symptoms: drug use consequences and intervening processes. J Health Soc Behav (1990) 1.08
Synexin-like proteins from human polymorphonuclear leukocytes. Identification and characterization of granule-aggregating and membrane-fusing activities. J Biol Chem (1987) 1.08
Polymorphonuclear Leukocyte lysosomes and immune tissue injury. Prog Allergy (1976) 1.07
Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest (1992) 1.07
Identification of the minimum regulatory region of a Myxococcus xanthus A-signal-dependent developmental gene. J Bacteriol (1995) 1.07
Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction. Am J Cardiol (1991) 1.06
Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system. Inflammation (1980) 1.04
Self-derogation and psychosocial adjustment. J Nerv Ment Dis (1969) 1.04
Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 1.03
Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]. J Clin Oncol (1988) 1.02
A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes. J Biol Chem (1983) 1.02
Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha. Infect Immun (1987) 1.02
Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect Immun (1984) 1.02
Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion (1971) 1.01
Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma. J Immunol (1981) 1.01
Prostaglandins, thromboxanes, and polymorphonuclear leukocytes: mediation and modulation of inflammation. Inflammation (1977) 1.00
Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum (1986) 0.99
Application of a general theory of deviant behavior: self-derogation and adolescent drug use. J Health Soc Behav (1982) 0.99
Myxococcus xanthus sasS encodes a sensor histidine kinase required for early developmental gene expression. J Bacteriol (1997) 0.98
Infections and hypocomplementemia. Annu Rev Med (1983) 0.97
The secretory code of the neutrophil. J Reticuloendothel Soc (1979) 0.97
Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. N Engl J Med (1981) 0.97
Chemotactic activity of C5ades Arg: evidence of a requirement for an anionic peptide 'helper factor' and inhibition by a cationic protein in serum from patients with systemic lupus erythematosus. Mol Immunol (1980) 0.97
Identification and characterization of genes required for early Myxococcus xanthus developmental gene expression. J Bacteriol (2000) 0.95
Influence of sympathetic stimulation and parasympathetic withdrawal on Doppler echocardiographic left ventricular diastolic filling velocities in young normal subjects. Am J Cardiol (1991) 0.94
Evidence of complement catabolism in acute pancreatitis. Am J Med Sci (1978) 0.94
Effect of high-dose methylprednisolone infusion on polymorphonuclear leukocyte function in patients with systemic lupus erythematosus. Arthritis Rheum (1981) 0.93
Effects of bacterial endotoxin on the fibrinolytic activity of normal human leukocytes. Blood (1971) 0.92
Evidence of complement catabolism in experimental acute pancreatitis. Am J Pathol (1980) 0.92
Biologically active peptides derived from the fifth component of complement. Prog Hemost Thromb (1980) 0.92
Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets. J Nucl Med (1989) 0.91
Toward a general theory of psychosocial deviance: the case of aggressive behavior. Soc Sci Med (1972) 0.91
Seasonal evaluation of outdoor/indoor air quality in primary schools in Lisbon. J Environ Monit (2011) 0.90
Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial. J Am Coll Cardiol (1988) 0.90
Escalation of marijuana use: application of a general theory of deviant behavior. J Health Soc Behav (1986) 0.90
Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light. J Clin Invest (1981) 0.89
Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann N Y Acad Sci (1982) 0.89